Farallon Capital Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,130,272
| Closed | -$7.23M | – | 171 |
|
|
2024
Q1 | $7.23M | Hold |
6,130,272
| – | – | 0.03% | 93 |
|
|
2023
Q4 | $5.59M | Hold |
6,130,272
| – | – | 0.03% | 87 |
|
|
2023
Q3 | $5.11M | Buy |
+6,130,272
| New | +$5.11M | 0.02% | 96 |
|
|
2021
Q3 | – | Sell |
-202,326
| Closed | -$1.64M | – | 301 |
|
|
2021
Q2 | $1.64M | Buy |
+202,326
| New | +$1.64M | 0.01% | 211 |
|
|
2020
Q3 | – | Sell |
-100,000
| Closed | -$1.3M | – | 127 |
|
|
2020
Q2 | $1.3M | Hold |
100,000
| – | – | 0.01% | 115 |
|
|
2020
Q1 | $1.02M | Sell |
100,000
-400,000
| -80% | -$4.06M | 0.01% | 96 |
|
|
2019
Q4 | $7.82M | Buy |
500,000
+399,288
| +396% | +$6.24M | 0.05% | 99 |
|
|
2019
Q3 | $1.69M | Buy |
100,712
+712
| +0.7% | +$12K | 0.01% | 94 |
|
|
2019
Q2 | $2.22M | Sell |
100,000
-277,852
| -74% | -$6.16M | 0.01% | 98 |
|
|
2019
Q1 | $8.19M | Buy |
+377,852
| New | +$8.19M | 0.06% | 83 |
|